Ad is loading...
IGMSX
Price
$7.91
Change
-$0.01 (-0.13%)
Updated
Nov 15 closing price
RNPGX
Price
$64.77
Change
-$0.94 (-1.43%)
Updated
Nov 15 closing price
Ad is loading...

IGMSX vs RNPGX

Header iconIGMSX vs RNPGX Comparison
Open Charts IGMSX vs RNPGXBanner chart's image
Voya Global Insights Portfolio S
Price$7.91
Change-$0.01 (-0.13%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R6
Price$64.77
Change-$0.94 (-1.43%)
VolumeN/A
CapitalizationN/A
IGMSX vs RNPGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IGMSX vs. RNPGX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGMSX is a Buy and RNPGX is a StrongSell.

FUNDAMENTALS
Fundamentals
RNPGX has more cash in the bank: 142B vs. IGMSX (1.12B). RNPGX pays higher dividends than IGMSX: RNPGX (1.11) vs IGMSX (0.00). IGMSX was incepted earlier than RNPGX: IGMSX (23 years) vs RNPGX (16 years). IGMSX is a more actively managed with annual turnover of: 107.00 vs. RNPGX (17.00). IGMSX has a lower initial minimum investment than RNPGX: IGMSX (0) vs RNPGX (250). RNPGX annual gain was more profitable for investors over the last year : 18.52 vs. IGMSX (-50.09). RNPGX return over 5 years is better than : 40.54 vs. IGMSX (-55.57).
IGMSXRNPGXIGMSX / RNPGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years16 years-
Gain YTD-52.57815.805-333%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.12B142B1%
Annual Yield % from dividends0.001.11-
Returns for 1 year-50.0918.52-270%
Returns for 3 years-69.29-9.39738%
Returns for 5 years-55.5740.54-137%
Returns for 10 years-54.9569.74-79%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLDI2.190.18
+8.96%
Calidi Biotherapeutics
EIX83.681.55
+1.89%
Edison International
ECPG49.220.83
+1.72%
Encore Capital Group
HWC58.45-0.96
-1.62%
Hancock Whitney Corp
ZNTL3.47-0.48
-12.15%
Zentalis Pharmaceuticals